Chawnshang Chang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Topics

Renal Cell Carcinoma

Signaling Pathway

Prostate Cancer

Top Venues

Cell death & disease

Cell & bioscience

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jinbo Chen, Chi-Ping Huang, Chao Quan, Xiongbing Zu, Zhenyu Ou, Yu-Chieh Tsai, Edward Messing, Shuyuan Yeh, Chawnshang Chang
The androgen receptor in bladder cancer. Nature reviews. Urology (2023)
Lei Chen, Yin Sun, Min Tang, Denglong Wu, Zhendong Xiang, Chi-Ping Huang, Bosen You, Dongdong Xie, Qinglin Ye, Dexin Yu, Chawnshang Chang
High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling. Cell death discovery 8 (1) (2022)
Qing Liu, Bosen You, Jia-Lin Meng, Chi-Ping Huang, Guanglu Dong, Ronghao Wang, Fuju Chou, Shan Gao, Chawnshang Chang, Shuyuan Yeh, Wanhai Xu
Targeting the androgen receptor to enhance NK cell killing efficacy in bladder cancer by modulating ADAR2/circ_0001005/PD-L1 signaling. Cancer gene therapy (2022)
Min Tang, Yin Sun, Chi-Ping Huang, Lei Chen, Bianjiang Liu, Bosen You, Zengjun Wang, Chawnshang Chang
High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals. Cell death & disease 13 (8) (2022)
Changcheng Guo, Yin Sun, Wei Zhai, Xudong Yao, Dongkui Gong, Bosen You, Chi-Ping Huang, Junhua Zheng, Chawnshang Chang
Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis. Cell & bioscience 12 (1) (2022)
Kuo-Chung Lan, Kuo-Ting Wei, Pei-Wen Lin, Ching-Chen Lin, Pei-Ling Won, Ya-Fen Liu, Yun-Ju Chen, Bi-Hua Cheng, Tien-Min G Chu, Jia-Feng Chen, Ko-En Huang, Chawnshang Chang, Hong-Yo Kang
Targeted activation of androgen receptor signaling in the periosteum improves bone fracture repair. Cell death & disease 13 (2) (2022)
Gang Deng, Ronghao Wang, Yin Sun, Chi-Ping Huang, Shuyuan Yeh, Bosen You, Changyong Feng, Gonghui Li, Shenglin Ma, Chawnshang Chang
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals. Cell death and differentiation 28 (7) (2021)
Bosen You, Yin Sun, Jie Luo, Keliang Wang, Qing Liu, Ruizhe Fang, Bingmei Liu, Fuju Chou, Ronghao Wang, Jialin Meng, Chi-Ping Huang, Shuyuan Yeh, Chawnshang Chang, Wanhai Xu
Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene 40 (9) (2021)
Meng Zhang, Yin Sun, Chi-Ping Huang, Jie Luo, Li Zhang, Jialin Meng, Chao-Zhao Liang, Chawnshang Chang
Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression. Cell death & disease 12 (10) (2021)
Zhendong Xiang, Yin Sun, Bosen You, Meng Zhang, Chiping Huang, Junfeng Yu, Xiangyun You, Denglong Wu, Chawnshang Chang
Suppressing BCL-XL increased the high dose androgens therapeutic effect to better induce the Enzalutamide-resistant prostate cancer autophagic cell death. Cell death & disease 12 (1) (2021)
Jinbo Chen, Yin Sun, Zhenyu Ou, Shuyuan Yeh, Chi-Ping Huang, Bosen You, Yu-Chieh Tsai, Tzong-Jen Sheu, Xiongbing Zu, Chawnshang Chang
Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion. EMBO reports 21 (4) (2020)
Bianjiang Liu, Yin Sun, Min Tang, Chao Liang, Chi-Ping Huang, Yuanjie Niu, Zengjun Wang, Chawnshang Chang
The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer. Cell death & disease 11 (9) (2020)
Fu-Ju Chou, ChangYi Lin, Hao Tian, WanYing Lin, Bosen You, Jieyang Lu, Deepak Sahasrabudhe, Chi-Ping Huang, Vanessa Yang, Shuyuan Yeh, Yuanjie Niu, Chawnshang Chang
Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer. Cell death & disease 11 (11) (2020)
Miao He, Weiwei Yu, Chawnshang Chang, Hiroshi Miyamoto, Xiaohong Liu, Ke Jiang, Shuyuan Yeh
Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways. Molecular oncology 14 (8) (2020)
Qing-Bo Huang, Yin Sun, Wei Zhai, Xin Ma, Donglai Shen, Songliang Du, Bosen You, Yuanjie Niu, Chi-Ping Huang, Xu Zhang, Chawnshang Chang
Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner. Oncogene 39 (43) (2020)
Mingchao Wang, Yin Sun, Junjie Xu, Jieyang Lu, Kefeng Wang, Dong-Rong Yang, Guosheng Yang, Gonghui Li, Chawnshang Chang
Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling. International journal of cancer 143 (1) (2018)